Ara
Toplam kayıt 11, listelenen: 1-10
Birinci basamak sağlık çalışanlarında COVID-19 görülme sıklığı
(2022)
COVID-19 pandemisiyle mücadelede ön safta görev yapan sağlık çalışanlarında hastalığa yakalanma riski toplumun birçok kesimine kıyasla daha yüksektir. Risk altındaki bazı grupların zaman zaman taranması vakaların erken ...
A randomized, double-blind, placebo-controlled, multicenter study to evaluate the safety and efficacy of thymoquinone formula (TQF) for treating outpatient SARS-CoV-2
(MDPI, 2022)
There is an urgent need for an oral drug for the treatment of mild to moderate outpatient SARS-CoV-2. Our preclinical and clinical study's aim was to determine the safety and preliminary efficacy of oral TQ Formula (TQF), ...
The mosaic of autoimmunity – Finally discussing in person. The 13th international congress on autoimmunity 2022 (AUTO13) Athens
(Elsevier B.V., 2022)
While autoimmunity is a branch of medicine linked to every single organ system via direct and indirect pathways, meeting in person to discuss autoimmunity during the 13th international congress on autoimmunity (AUTO13) ...
Bradycardia in a patient with severe COVID-19
(NLM (Medline), 2022)
BACKGROUND: Heart rate disorders and in particular sinus arrhythmias are known to accompany viral infections. Sinus tachycardia is prevalent in the presence of increased body temperature and respiratory rate. However, ...
Efficacy and safety profile of COVID-19 vaccine in cancer patients: A prospective, multicenter cohort study
(Future Medicine Ltd, 2022)
Aim: To compare the seropositivity rate of cancer patients with non-cancer controls after inactive SARS-CoV-2 vaccination (CoronaVac) and evaluate the factors affecting seropositivity. Method: Spike IgG antibodies against ...
Headache onset after vaccination against SARS-CoV-2: A systematic literature review and meta-analysis
(BMC, 2022)
Background Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are used to reduce the risk of developing Coronavirus Disease 2019 (COVID-19). Despite the significant benefits in terms of reduced ...
The COVID-19 pandemic – How many times were we warned before?
(Elsevier B.V., 2022)
Infectious diseases are known to act in both predictable and unpredictable ways, which leads to the notions of emerging and reemerging infectious diseases. Emerging diseases with their disastrous consequences might be ...
COVID-19 pozitif hastalarda SARS-CoV-2 varyantlarının prevalansı
(DOC Design and Informatics Co. Ltd., 2022)
Amaç: Dünya Sağlık Örgütü (DSÖ) tarafından alfa (B.1.1.7), beta (B.1.351), gamma (P.1), delta (B.1.617.2) ve omic - ron (B.1.1.529) endişe verici varyantlar (“variants of concern – VOCs”) olarak sınıflandırılmıştır. ...
A bibliometric analysis of pneumonia articles (2016-2020)
(Eskişehir Osmangazi University, 2022)
Lower respiratory infections are one of the leading factors of death in the world. During the COVID-19 pandemic, pneumonia comes to the fore from respiratory diseases. We aim to close the information gap regarding the ...
Mesenchymal stem cell-based COVID-19 therapy: Bioengineering perspectives
(MDPI, 2022)
The novel pathogenic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19). Mesenchymal stem cells (MSCs) are currently utilized in clinics for pulmonary inflammatory ...